| Literature DB >> 27080832 |
Abstract
Pharmacovigilance aims to identify unknown adverse drug reactions once clinical development is complete, in order to promote improved use of drugs, and thus a reduction in risk for every exposed patient. We describe in this article the missions of French pharmacovigilance system, including French drug agency, Regional Centers of Pharmacovigilance, health professionals, pharmaceutical companies, patients and their associations. We also develop the French pharmacovigilance organization, its perspectives and challenges, both in French and European levels.Entities:
Keywords: Adverse drug reactions; Drug safety; Pharmacovigilance
Mesh:
Year: 2016 PMID: 27080832 DOI: 10.1016/j.therap.2016.02.029
Source DB: PubMed Journal: Therapie ISSN: 0040-5957 Impact factor: 2.070